CyBio AG Adds to Top Management
(Thomson Reuters ONE) - Corporate news announcement processed and transmitted by Hugin AS.The issuer is solely responsible for the content of this announcement. ------------------------------------------------------------------------------------ Jena, Germany, August 28, 2009 - The Supervisory Board of CyBio AG(Deutsche Börse: General Standard, ISIN-Number DE0005412308)appointed Thomas Moore as a member of the Company's ExecutiveManagement Board responsible for Sales and R&D effective September 1,2009. The appointment of the 53 year old Thomas Moore, who has workedfor the Company since its foundation in 1996, is meant to bundle andto further strengthen the responsibilities in these areas. CyBio willnot be effected with additional costs due to the expansion of themanagement.Thomas Moore, who has directed the Company OPALJENA, that has beentraded as CyBio Instruments since 1999, as Executive Manager until2002. From 1991 to 1996 he managed the R&D activities of JENOPTRON.Moore possesses broad experience in the fields of optics,optoelectronics, lab automation and liquid handling. Recently hemanaged the new life science department at CyBio AG, that willprospectively contribute to the Company`s sales increase."The restructuring and the strengthening of the sales unit areimportant success factors for the further development of CyBio", saysJens Adomat, who has been interim Executive Board of the Companysince August 18, 2009. "Major objectives will be to consistentlycontinue the integration measures, to optimize existing processes interms of cost reduction, and to realize synergy effects and salesopportunities. It is also necessary to force the R&D activities. WithThomas Moore we have an experienced manager on board, who knows thehts-pharmaceutical market and CyBio`s customers very well. With thisappointment we strengthen our business at a critical point."Contact:CyBio AGGoeschwitzer Str. 4007745 JenaTel.: + 49 3641.351 495Fax: + 49 3641.351 409E-Mail: irpr (at)cybio-ag.comhttp://hugin.info/131259/R/1338088/319138.pdf --- End of Message ---CyBio AGGöschwitzer Straÿe 40 Jena GermanyWKN: 541230; ISIN: DE0005412308; Index: CDAX;Listed: General Standard in Frankfurter Wertpapierbörse, Freiverkehr in Bayerische Börse München, Freiverkehr in Börse Stuttgart, Freiverkehr in Börse Berlin, Freiverkehr in Börse Düsseldorf, Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg, Freiverkehr in Niedersächsische Börse zu Hannover, Regulierter Markt in Frankfurter Wertpapierbörse;
Datum: 28.08.2009 - 17:23 Uhr
Sprache: Deutsch
News-ID 5247
Anzahl Zeichen: 0
contact information:
Town:
London
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 413 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"CyBio AG Adds to Top Management"
steht unter der journalistisch-redaktionellen Verantwortung von
CyBio AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
